Transcriptomics

Dataset Information

0

Whole transcriptome sequencing for wild type and IRAIN over-expression K562 cells


ABSTRACT: The development of tyrosine kinase inhibitors (TKIs) has revolutionarily increased the overall survival of patients with chronic myeloid leukemia (CML). However, drug resistance remains a major obstacle. Here, we demonstrated that a BCR-ABL1-independent long non-coding RNA, IRAIN, is constitutively expressed at low levels in CML, resulting in imatinib resistance. IRAIN knockdown decreased the sensitivity of CD34+ CML blasts and cell lines to imatinib, whereas IRAIN overexpression significantly increased sensitivity. Mechanistically, IRAIN downregulates CD44, a membrane receptor favorably affecting TKI resistance, by binding to the nuclear factor kappa B subunit p65 to reduce the expression of p65 and phosphorylated p65. Therefore, the demethylating drug decitabine, which upregulates IRAIN, combined with imatinib, formed a dual therapy strategy which can be applied to CML with resistance to TKIs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE263645 | GEO | 2024/04/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-15 | GSE226360 | GEO
2024-09-15 | GSE275701 | GEO
2024-01-01 | E-MTAB-11896 | biostudies-arrayexpress
2024-01-01 | E-MTAB-11899 | biostudies-arrayexpress
2022-02-16 | PXD028779 | Pride
2016-01-17 | E-GEOD-75615 | biostudies-arrayexpress
2014-10-07 | E-GEOD-62121 | biostudies-arrayexpress
2023-03-01 | GSE208313 | GEO
2023-03-01 | GSE208312 | GEO
2023-03-01 | GSE207627 | GEO